Merck secures $700 million funding from Blackstone to develop cancer therapy
PositiveFinancial Markets

Merck has successfully secured $700 million in funding from Blackstone to advance its cancer therapy development. This significant investment highlights the growing confidence in Merck's innovative approaches to treating cancer, which could lead to breakthroughs in patient care and potentially save lives. The collaboration between a pharmaceutical giant and a leading investment firm underscores the importance of financial support in the fight against cancer.
— Curated by the World Pulse Now AI Editorial System









